Management of Unruptured Small Multiple Intracranial Aneurysms in China: A Comparative Effectiveness Analysis Based on Real-World Data

被引:3
|
作者
Chen, Jigang [1 ,2 ]
Tong, Xin [1 ,2 ]
Feng, Xin [3 ]
Peng, Fei [1 ,2 ]
Niu, Hao [1 ,2 ]
Han, Mingyang [4 ]
Liu, Lang [4 ]
Zhao, Yuanli [5 ]
Wang, Daming [3 ]
Pan, Yuesong [6 ,7 ]
Liu, Aihua [1 ,2 ,7 ]
机构
[1] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Beijing, Peoples R China
[3] Beijing Hosp, Natl Ctr Gerontol, Dept Neurosurg, Beijing, Peoples R China
[4] Cent South Univ, Xiangya Hosp 3, Dept Neurosurg, Changsha, Peoples R China
[5] Peking Univ, Peking Univ Int Hosp, Dept Neurosurg, Beijing, Peoples R China
[6] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[7] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2022年 / 12卷
关键词
multiple intracranial aneurysms; small aneurysm; comparative effectiveness analysis; real-world data; endovascular therapy; ENDOVASCULAR TREATMENT; COST-EFFECTIVENESS; PREVALENCE; MORTALITY; RISK; COILING; STROKE; SEX; AGE;
D O I
10.3389/fneur.2021.736127
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundUnruptured small aneurysms with a size of <7 mm were often followed conservatively. However, it is unknown whether unruptured small multiple intracranial aneurysms (MIAs) are better to be prophylactically treated or conservatively followed. ObjectiveWe aim to compare the effectiveness of different strategies regarding their management. MethodsA decision-analytic Markov model was built over a entire life cycle. The compared strategies include natural history, treat one aneurysm, treat both aneurysms, annual follow-up, biennial follow-up, and follow-up every 5 years. The inputs for the model were obtained from real-world data and related medical literature. Outcomes were measured in terms of quality-adjusted life-years (QALYs). ResultsTreat both aneurysms had the highest effectiveness of 15.36 QALYs and treat one aneurysm had the second-highest effectiveness of 15.11 QALYs. Probabilistic sensitivity analysis with 10,000 iterations showed that treat both aneurysms and treat one aneurysm were optimal in 67.28 and 17.91% of all cases, respectively. One-way and two-way sensitivity analyses showed that the result was sensitive to the proportion of moderate to severe disability after treating two aneurysms, mortality after treating two aneurysms, proportion of moderate to severe disability after treating one aneurysm, and rupture rate of small growing aneurysm. Either treat both aneurysms or treat one aneurysm would be the optimal strategy under most of the circumstances with the variations of these parameters. ConclusionFor patients with small unruptured MIAs, prophylactic coiling was superior to conservative management and at least one aneurysm should be treated.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Clinical Management of COPD in a Real-World Setting. A Big Data Analysis
    Luis Izquierdo, Jose
    Morena, Diego
    Gonzalez, Yolanda
    Manuel Paredero, Jose
    Perez, Bernardino
    Graziani, Desiree
    Gutierrez, Matilde
    Miguel Rodriguez, Jose
    ARCHIVOS DE BRONCONEUMOLOGIA, 2021, 57 (02): : 94 - 100
  • [42] REAL-WORLD NON-PERSISTENCE WITH ORAL MULTIPLE MYELOMA TREATMENTS: A COMPARATIVE ANALYSIS OF METHODOLOGIES USING CLAIMS DATA
    Kocaata, Z.
    Mueller, S.
    Maywald, U.
    Wilke, T.
    VALUE IN HEALTH, 2021, 24 : S48 - S48
  • [43] Driving Characteristics Analysis Method Based on Real-World Driving Data
    Lee, Sangho
    Eom, Injae
    Lee, Beomho
    Won, Janghyeok
    ENERGIES, 2024, 17 (01)
  • [44] Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia
    AlRuthia, Yazed
    Alfakhri, Almaha H.
    Alharbi, Ibtisam
    Alghamdi, Fadi Ali
    Alanazi, Miteb A.
    Alrabiah, Abdullah Abdulrahman
    Alsouan, Anwar Abdulrazzag
    Alshaikh, Abdulrahman Abdullah
    Almasaoud, Majed Ali
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2023, 21 (01)
  • [45] Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia
    Yazed AlRuthia
    Almaha H. Alfakhri
    Ibtisam Alharbi
    Fadi Ali Alghamdi
    Miteb A. Alanazi
    Abdullah Abdulrahman Alrabiah
    Anwar Abdulrazzag Alsouan
    Abdulrahman Abdullah Alshaikh
    Majed Ali Almasaoud
    Cost Effectiveness and Resource Allocation, 21
  • [46] COMPARATIVE EFFECTIVENESS ANALYSIS OF TNF BLOCKERS IN RHEUMATOID ARTHRITIS (RA) PATIENTS IN A REAL-WORLD SETTING
    Bonafede, R. P.
    Pearson, D.
    Babich, J.
    Chastek, B.
    Becker, L.
    Watson, C.
    Chaudhari, S.
    Harrison, D. J.
    Gandra, S. R.
    VALUE IN HEALTH, 2011, 14 (03) : A1 - A2
  • [47] The state of real-world evidence in comparative effectiveness and safety studies based on healthcare insurance claims
    Bykov, Katsiaryna
    Patorno, Elisabetta
    He, Mengdong
    Lee, Hemin
    D'Andrea, Elvira
    Graff, Jennifer S.
    Franklin, Jessica M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 418 - 418
  • [48] Analytic and Data Sharing Options in Real-World Multidatabase Studies of Comparative Effectiveness and Safety of Medical Products
    Toh, Sengwee
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 834 - 842
  • [49] REAL-WORLD EVIDENCE ON ECONOMIC BURDEN OF MULTIPLE MYELOMA IN CHINA: A RETROSPECTIVE STUDY OF CLAIMS DATA
    Wang, J.
    Zhang, X.
    Liu, S.
    Sun, R.
    Liu, J.
    VALUE IN HEALTH, 2020, 23 : S51 - S51
  • [50] Multidisciplinary stakeholder engagement in a type 2 diabetes comparative effectiveness study utilizing real-world data
    Golembiewski, Elizabeth H.
    Mickelson, Mindy M.
    Brito, Juan P.
    Montori, Victor M.
    Mccoy, Rozalina G.
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 8 (01)